Literature DB >> 27236746

Impact of Cirrhosis on Resource Use and Inpatient Complications in Patients Undergoing Total Knee and Hip Arthroplasty.

Jared M Newman1, Nicholas K Schiltz2, Christopher D Mudd1, Caleb R Szubski1, Alison K Klika1, Wael K Barsoum1.   

Abstract

BACKGROUND: Cirrhosis is a major cause of morbidity and mortality and is an important risk factor for complications in surgical patients. The purpose of this study was to investigate the association of cirrhosis with postoperative complications, length of stay (LOS), and costs among patients who underwent total knee arthroplasty (TKA) or total hip arthroplasty (THA).
METHODS: Using the Nationwide Inpatient Sample between 2000 and 2011, we identified patients who had a primary TKA or primary THA. TKA patients were divided into 2 groups: (1) cirrhosis (n = 41,464) and (2) no cirrhosis (n = 5,721,297) and THA patients were divided into 2 groups: (1) cirrhosis (n = 27,401) and (2) no cirrhosis (n = 2,622,539). Patient demographics, comorbidities, perioperative complications, LOS, and incremental costs were analyzed. An additional subgroup analysis by cirrhosis etiology was performed.
RESULTS: Multivariable analysis revealed cirrhosis was associated with 1.55 (95% confidence interval: 1.47-1.63) times higher odds of any complication after TKA and 1.59 (1.50-1.69) higher odds after THA. Adjusted outcomes showed cirrhotic TKA patients had $1857 higher costs and 0.30 days longer LOS and THA cirrhotic patients had $1497 higher costs and 0.48 longer LOS. We found similar results for each cirrhosis subtype but alcohol-related had the highest resource use and complication rate.
CONCLUSION: Patients with cirrhosis who are undergoing TKA or THA are at a significantly increased risk for perioperative complications, increased LOS, and higher costs. The perioperative complications and costs were highest among patients with alcohol-related cirrhosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cirrhosis; complications; cost; length of stay; total hip arthroplasty; total knee arthroplasty

Mesh:

Year:  2016        PMID: 27236746      PMCID: PMC5069119          DOI: 10.1016/j.arth.2016.04.011

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  32 in total

1.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

2.  Preoperative predictors of extended hospital length of stay following total knee arthroplasty.

Authors:  Mohamad J Halawi; Tyler J Vovos; Cindy L Green; Samuel S Wellman; David E Attarian; Michael P Bolognesi
Journal:  J Arthroplasty       Date:  2014-10-25       Impact factor: 4.757

3.  Alcohol Misuse is an Independent Risk Factor for Poorer Postoperative Outcomes Following Primary Total Hip and Total Knee Arthroplasty.

Authors:  Matthew J Best; Leonard T Buller; Raul G Gosthe; Alison K Klika; Wael K Barsoum
Journal:  J Arthroplasty       Date:  2015-02-28       Impact factor: 4.757

Review 4.  Thrombocytopenia associated with chronic liver disease.

Authors:  Nezam Afdhal; John McHutchison; Robert Brown; Ira Jacobson; Michael Manns; Fred Poordad; Babette Weksler; Rafael Esteban
Journal:  J Hepatol       Date:  2008-03-31       Impact factor: 25.083

Review 5.  Hemostasis in liver disease: implications of new concepts for perioperative management.

Authors:  Pepijn D Weeder; Robert J Porte; Ton Lisman
Journal:  Transfus Med Rev       Date:  2014-03-15

6.  The risk of perioperative adverse events in patients with chronic liver disease.

Authors:  Tae Hyung Kim; Soon Ho Um; Sun Young Yim; Yeon Seok Seo; Hyung Joon Yim; Yoon Tae Jeen; Hong Sik Lee; Hoon Jae Chun; Chang Duck Kim; Hyonggin Ahn; Yeji Lee
Journal:  Liver Int       Date:  2014-04-04       Impact factor: 5.828

7.  Fibrosis in hepatitis C patients predicts complications after elective total joint arthroplasty.

Authors:  Fabio Orozco; Zachary D Post; Omkar Baxi; Adam Miller; Alvin Ong
Journal:  J Arthroplasty       Date:  2013-05-04       Impact factor: 4.757

8.  Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009.

Authors:  Alison K Klika; Travis J Small; Anas Saleh; Caleb R Szubski; Aiswarya Lekshmi Pillai Chandran Pillai; Wael K Barsoum
Journal:  J Arthroplasty       Date:  2014-06-28       Impact factor: 4.757

Review 9.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

10.  Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease.

Authors:  Young-Wan Moon; Yong-Sik Kim; Soon-Yong Kwon; Shin-Yoon Kim; Seung-Jae Lim; Youn-Soo Park
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

View more
  8 in total

1.  Parkinson's disease increases the risk of perioperative complications after total knee arthroplasty: a nationwide database study.

Authors:  Jared M Newman; Nipun Sodhi; Alyeesha B Wilhelm; Anton Khlopas; Alison K Klika; Qais Naziri; Thomas J Kryzak; Carlos A Higuera; Michael A Mont
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-05-21       Impact factor: 4.342

2.  Impact of Cirrhosis on Morbidity and Mortality After Spinal Fusion.

Authors:  Young Lu; Charles C Lin; Hayk Stepanyan; Andrew P Alvarez; Nitin N Bhatia; P Douglas Kiester; Charles D Rosen; Yu-Po Lee
Journal:  Global Spine J       Date:  2019-10-10

3.  Outcomes of Patients With Cirrhosis Undergoing Orthopedic Procedures: An Analysis of the Nationwide Inpatient Sample.

Authors:  Neehar D Parikh; Yu-Hui Chang; Elliot B Tapper; Amit K Mathur
Journal:  J Clin Gastroenterol       Date:  2019-10       Impact factor: 3.062

4.  The Impact of Medical Comorbidities on Primary Total Knee Arthroplasty Reimbursements.

Authors:  Karim G Sabeh; Samuel Rosas; Leonard T Buller; Andrew A Freiberg; Cynthia L Emory; Martin W Roche
Journal:  J Knee Surg       Date:  2018-05-23       Impact factor: 2.501

5.  Total hip arthroplasty in patients with chronic liver disease: A systematic review.

Authors:  Elliot Onochie; Babar Kayani; Sebastian Dawson-Bowling; Steven Millington; Pramod Achan; Sammy Hanna
Journal:  SICOT J       Date:  2019-11-04

6.  The Impact of Hepatitis C and Liver Disease on Risk of Complications After Total Hip and Knee Arthroplasty: Analysis of Administrative Data From Louisiana and Texas.

Authors:  Brett Salomon; Peter C Krause; Vinod Dasa; Lizheng Shi; Deryk Jones; Andrew G Chapple
Journal:  Arthroplast Today       Date:  2021-02-02

7.  Chronic liver disease and cirrhosis increase morbidity in geriatric patients treated surgically for hip fractures: analysis of the US Nationwide Inpatient Sample.

Authors:  Feng-Jen Tseng; Guo-Hau Gou; Sheng-Hao Wang; Jia-Fwu Shyu; Ru-Yu Pan
Journal:  BMC Geriatr       Date:  2022-02-23       Impact factor: 3.921

8.  Failure to Medically Optimize Before Total Hip Arthroplasty: Which Modifiable Risk Factor Is the Most Dangerous?

Authors:  Joseph M Statz; Susan M Odum; Nicholas R Johnson; Jesse E Otero
Journal:  Arthroplast Today       Date:  2021-07-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.